Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Ascentage Pharma Group International - Unsponsored ADR (AAPG) had Free Cash Flow per Share of $-1.93 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$82.10M |
|
$-177.71M |
|
$7.00M |
|
$75.10M |
|
$251.16M |
|
$-169.07M |
|
$-7.69M |
|
$-176.75M |
|
$-176.75M |
|
$-177.75M |
|
$-177.75M |
|
$-177.75M |
|
$-177.75M |
|
$-169.07M |
|
$-158.22M |
|
89.03M |
|
89.03M |
|
$-2.00 |
|
$-2.00 |
|
| Balance Sheet Financials | |
$421.01M |
|
$111.72M |
|
$145.77M |
|
$566.78M |
|
$235.00M |
|
$108.28M |
|
$141.00M |
|
$375.99M |
|
$190.79M |
|
$177.83M |
|
$190.79M |
|
93.33M |
|
| Cash Flow Statement Financials | |
$-167.90M |
|
$-143.01M |
|
$363.23M |
|
$127.71M |
|
$171.00M |
|
$43.28M |
|
$2.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.79 |
|
-- |
|
-- |
|
0.36 |
|
1.48 |
|
91.48% |
|
-205.93% |
|
-205.93% |
|
-192.72% |
|
-215.30% |
|
-216.47% |
|
$-171.84M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
1.71 |
|
2.27 |
|
160.81 |
|
-93.16% |
|
-99.95% |
|
-31.36% |
|
-59.43% |
|
$2.04 |
|
|
Free Cash Flow per Share |
$-1.93 |
$-1.89 |
|